Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-25-010 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to continue support for a nonhuman primate (NHP) reagent resource that enables rigorous and reproducible research in NHP models through the development, production, and distribution of NHP-specific immunologic reagents that are not commercially available or, if commercially available, are not optimized for use in NHPs. The over-arching goal is to accelerate cures, vaccines, and treatments for immune-mediated diseases and emerging and reemerging infectious diseases by facilitating robust preclinical research in NHPs.